ENLV
Price
$0.97
Change
+$0.05 (+5.43%)
Updated
Jun 6 closing price
Capitalization
21.94M
72 days until earnings call
OCUL
Price
$9.02
Change
+$0.56 (+6.62%)
Updated
Jun 6 closing price
Capitalization
1.35B
65 days until earnings call
Interact to see
Advertisement

ENLV vs OCUL

Header iconENLV vs OCUL Comparison
Open Charts ENLV vs OCULBanner chart's image
Enlivex Therapeutics
Price$0.97
Change+$0.05 (+5.43%)
Volume$57.6K
Capitalization21.94M
Ocular Therapeutix
Price$9.02
Change+$0.56 (+6.62%)
Volume$2.15M
Capitalization1.35B
ENLV vs OCUL Comparison Chart
Loading...
ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENLV vs. OCUL commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENLV is a Hold and OCUL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (ENLV: $0.95 vs. OCUL: $7.89)
Brand notoriety: ENLV and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENLV: 156% vs. OCUL: 184%
Market capitalization -- ENLV: $21.94M vs. OCUL: $1.35B
ENLV [@Biotechnology] is valued at $21.94M. OCUL’s [@Biotechnology] market capitalization is $1.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENLV’s FA Score shows that 1 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • ENLV’s FA Score: 1 green, 4 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, ENLV is a better buy in the long-term than OCUL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENLV’s TA Score shows that 5 TA indicator(s) are bullish while OCUL’s TA Score has 5 bullish TA indicator(s).

  • ENLV’s TA Score: 5 bullish, 5 bearish.
  • OCUL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ENLV and OCUL are a good buy in the short-term.

Price Growth

ENLV (@Biotechnology) experienced а -3.01% price change this week, while OCUL (@Biotechnology) price change was +8.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ENLV is expected to report earnings on Aug 18, 2025.

OCUL is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($1.35B) has a higher market cap than ENLV($21.9M). OCUL YTD gains are higher at: -7.611 vs. ENLV (-18.803). ENLV has higher annual earnings (EBITDA): -15.44M vs. OCUL (-176.14M). OCUL has more cash in the bank: 392M vs. ENLV (24.5M). ENLV has less debt than OCUL: ENLV (765K) vs OCUL (75.8M). OCUL has higher revenues than ENLV: OCUL (63.7M) vs ENLV (0).
ENLVOCULENLV / OCUL
Capitalization21.9M1.35B2%
EBITDA-15.44M-176.14M9%
Gain YTD-18.803-7.611247%
P/E RatioN/AN/A-
Revenue063.7M-
Total Cash24.5M392M6%
Total Debt765K75.8M1%
FUNDAMENTALS RATINGS
ENLV vs OCUL: Fundamental Ratings
ENLV
OCUL
OUTLOOK RATING
1..100
6113
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
52
Fair valued
PROFIT vs RISK RATING
1..100
10087
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
6162
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENLV's Valuation (19) in the Medical Specialties industry is somewhat better than the same rating for OCUL (52) in the Pharmaceuticals Other industry. This means that ENLV’s stock grew somewhat faster than OCUL’s over the last 12 months.

OCUL's Profit vs Risk Rating (87) in the Pharmaceuticals Other industry is in the same range as ENLV (100) in the Medical Specialties industry. This means that OCUL’s stock grew similarly to ENLV’s over the last 12 months.

ENLV's SMR Rating (97) in the Medical Specialties industry is in the same range as OCUL (98) in the Pharmaceuticals Other industry. This means that ENLV’s stock grew similarly to OCUL’s over the last 12 months.

ENLV's Price Growth Rating (61) in the Medical Specialties industry is in the same range as OCUL (62) in the Pharmaceuticals Other industry. This means that ENLV’s stock grew similarly to OCUL’s over the last 12 months.

ENLV's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as OCUL (100) in the Pharmaceuticals Other industry. This means that ENLV’s stock grew similarly to OCUL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENLVOCUL
RSI
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
82%
Bearish Trend 11 days ago
85%
Momentum
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
80%
MACD
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
87%
Bullish Trend 11 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
86%
Bullish Trend 11 days ago
87%
Advances
ODDS (%)
Bullish Trend about 1 month ago
75%
Bullish Trend 19 days ago
80%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 17 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
90%
Bearish Trend 11 days ago
80%
Aroon
ODDS (%)
Bullish Trend 11 days ago
57%
Bullish Trend 11 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ENLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENLV has been loosely correlated with APVO. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ENLV jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENLV
1D Price
Change %
ENLV100%
-4.52%
APVO - ENLV
36%
Loosely correlated
-6.50%
KURA - ENLV
31%
Poorly correlated
-1.07%
JANX - ENLV
28%
Poorly correlated
-2.23%
OCUL - ENLV
28%
Poorly correlated
+13.69%
HRTX - ENLV
25%
Poorly correlated
-3.17%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+13.69%
EYPT - OCUL
62%
Loosely correlated
+18.12%
IMVT - OCUL
52%
Loosely correlated
-1.33%
DNLI - OCUL
51%
Loosely correlated
-1.29%
XENE - OCUL
49%
Loosely correlated
-3.29%
BEAM - OCUL
49%
Loosely correlated
-0.88%
More